Angiodynamic Inc (NASDAQ: ANGO) on Monday, soared 3.67% from the previous trading day, before settling in for the closing price of $9.00. Within the past 52 weeks, ANGO’s price has moved between $5.26 and $9.42.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 2.66% over the last five years. The company achieved an average annual earnings per share of -5.26%. With a float of $38.70 million, this company’s outstanding shares have now reached $41.00 million.
The firm has a total of 748 workers. Let’s measure their productivity. In terms of profitability, gross margin is 49.71%, operating margin of -14.9%, and the pretax margin is -81.7%.
Angiodynamic Inc (ANGO) Insider Activity
Observing investor behavior towards Medical Instruments & Supplies industry stocks is more important than anything else. The insider ownership of Angiodynamic Inc is 4.76%, while institutional ownership is 79.28%. The most recent insider transaction that took place on Oct 07 ’24, was worth 4,677. In this transaction SVP Quality and Regulatory of this company bought 768 shares at a rate of $6.09, taking the stock ownership to the 45,777 shares. Before that another transaction happened on Oct 10 ’24, when Company’s SVP Quality and Regulatory bought 100 for $6.08, making the entire transaction worth $608. This insider now owns 45,877 shares in total.
Angiodynamic Inc (ANGO) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around -5.26% per share during the next fiscal year.
Angiodynamic Inc (NASDAQ: ANGO) Trading Performance Indicators
Angiodynamic Inc (ANGO) is currently performing well based on its current performance indicators. A quick ratio of 1.41 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.27.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -6.04, a number that is poised to hit -0.11 in the next quarter and is forecasted to reach -0.22 in one year’s time.
Technical Analysis of Angiodynamic Inc (ANGO)
Analysing the last 5-days average volume posted by the [Angiodynamic Inc, ANGO], we can find that recorded value of 0.64 million was better than the volume posted last year of 0.53 million. As of the previous 9 days, the stock’s Stochastic %D was 89.02%. Additionally, its Average True Range was 0.42.
During the past 100 days, Angiodynamic Inc’s (ANGO) raw stochastic average was set at 95.37%, which indicates a significant increase from 93.51% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 86.44% in the past 14 days, which was higher than the 59.32% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $7.07, while its 200-day Moving Average is $6.69. Now, the first resistance to watch is $9.53. This is followed by the second major resistance level at $9.74. The third major resistance level sits at $9.97. If the price goes on to break the first support level at $9.09, it is likely to go to the next support level at $8.86. Should the price break the second support level, the third support level stands at $8.65.
Angiodynamic Inc (NASDAQ: ANGO) Key Stats
Market capitalization of the company is 371.69 million based on 40,634K outstanding shares. Right now, sales total 303,910 K and income totals -184,350 K. The company made 67,490 K in profit during its latest quarter, and -12,800 K in sales during its previous quarter.
